Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-18T14:43:35.515Z Has data issue: false hasContentIssue false

Contribution of cod liver oil supplements to intake and associations with biomarkers of fatty acids in the European Prospective Investigation into Cancer (EPIC-Norfolk) Study

Published online by Cambridge University Press:  15 August 2011

M. A. H. Lentjes
Affiliation:
Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN
A. Bhaniani
Affiliation:
Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN
A. A. Mulligan
Affiliation:
Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN
A. A. Welch
Affiliation:
Norwich Medical School, University of East Anglia, Norwich
K. T. Khaw
Affiliation:
Clinical Gerontology, University of Cambridge, Cambridge
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2011

Supplements contribute to nutrient intakes and are used by 34% of men and 46% of women participating in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk)(Reference Lentjes, Bhaniani and Mulligan1). As cod liver oil (CLO) supplements are the most frequently consumed group, this cross-sectional study aimed to assess their contribution to nutrient intakes, (EPA, DHA and vitamins A and D) and to determine whether inclusion of supplement data improved the association between nutrient intake and corresponding biomarkers, i.e. blood plasma concentrations of EPA and DHA.

EPIC-Norfolk is a prospective cohort study investigating determinants of chronic diseases in free-living individuals, aged 40–79 years, recruited from the general population between 1993 and 1998(Reference Day, Oakes and Luben2). Participants filled in a 7-d diet diary(Reference Welch, McTaggart and Mulligan3, Reference Bingham, Welch and McTaggart4), in which they also recorded their dietary supplement use(Reference Lentjes, Bhaniani and Mulligan1).

Chi-square tests indicated that supplement use increased with age in men only (P trend<0.001) and that the proportion of CLO containing supplements increased with age for men and women (P trend<0.001). Median nutrient intake increased after inclusion of supplement sources (Table); and resulted in a shift in the quintile distribution for 18–26% of the participants for fatty acids and for 36–51% of the participants for vitamins A and D.

Participants were divided into three groups: non-supplement users (NSU◆), supplement users not using CLO (SU-CLO▪) and SU using CLO (SU+CLO▴). In participants with blood plasma concentrations (n 3371 men, n 3174 women), ANOVA showed higher plasma levels for EPA (40%) and DHA (19%) for the SU+CLO compared with NSU, after correcting for quintiles of food sources of respective fatty acids (P<0.001, Figure).

Consumption of supplements contributed to intakes of EPA, DHA and vitamins A and D and had substantial effects on classification of individuals within this population distribution. The association between intake and plasma fatty acids were similar for SU and NSU, but the absolute values for SU were higher, demonstrating the contribution supplements make. Omitting data for intakes from supplements could be a source of error in diet and disease associations.

References

1.Lentjes, MA, Bhaniani, A, Mulligan, AA et al. (2011) Public Health Nutr 17, 113.Google Scholar
2.Day, N, Oakes, S, Luben, R et al. (1999) Br J Cancer 80, 95103.Google Scholar
3.Welch, AA, McTaggart, A, Mulligan, AA et al. (2001) Public Health Nutr 4, 12531265.CrossRefGoogle Scholar
4.Bingham, SA, Welch, AA, McTaggart, A et al. (2001) Public Health Nutr 4, 847858.CrossRefGoogle Scholar